Enzyme Inhibitor from Marine Organisms
Marine habitats are promising sources to identify novel organisms and compounds. A total of 70% of the planet's surface is covered by ocean, and little is known about the biosphere within these habitats. In the last few years, numerous novel bioactive compounds or secondary metabolites from mar...
Saved in:
Other Authors: | |
---|---|
Format: | Book Chapter |
Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2020
|
Subjects: | |
Online Access: | Get Fullteks DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 03339naaaa2200757uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_69424 | ||
005 | 20210501 | ||
020 | |a books978-3-03943-784-9 | ||
020 | |a 9783039437832 | ||
020 | |a 9783039437849 | ||
024 | 7 | |a 10.3390/books978-3-03943-784-9 |c doi | |
041 | 0 | |a English | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
100 | 1 | |a Tischler, Dirk |4 edt | |
700 | 1 | |a Tischler, Dirk |4 oth | |
245 | 1 | 0 | |a Enzyme Inhibitor from Marine Organisms |
260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
300 | |a 1 electronic resource (130 p.) | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Marine habitats are promising sources to identify novel organisms and compounds. A total of 70% of the planet's surface is covered by ocean, and little is known about the biosphere within these habitats. In the last few years, numerous novel bioactive compounds or secondary metabolites from marine environments have been described. This is, and will be, a promising source of candidate compounds in pharma research and chemical biology. In recent years, a number of novel techniques have been introduced to the field and it has become easier to actually (bio-)prospect compounds such as enzyme inhibitors. Those novel compounds then need to be characterized and evaluated in comparison to well-known representatives. This Special Issue focuses on the description of novel enzyme inhibitors of marine origin, including bioprospecting, omic approaches, and structural and mechanistic aspects. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
653 | |a sponge Monanchora pulchra | ||
653 | |a pentacyclic guanidine alkaloids | ||
653 | |a GH36 α-galactosidase | ||
653 | |a GH109 α-N-acetylgalactosaminidase | ||
653 | |a slow-binding irreversible inhibitor | ||
653 | |a monanchomycalin B | ||
653 | |a monanhocidin A | ||
653 | |a normonanhocidin A | ||
653 | |a Alzheimer's disease | ||
653 | |a BACE1 | ||
653 | |a acetylcholinesterase | ||
653 | |a in silico docking | ||
653 | |a phlorotannins | ||
653 | |a Ulva intestinalis | ||
653 | |a ACE inhibitory peptide | ||
653 | |a optimization | ||
653 | |a purification | ||
653 | |a structural identification | ||
653 | |a molecular docking | ||
653 | |a secondary metabolites | ||
653 | |a Mycosphaerella sp. | ||
653 | |a asperchalasine | ||
653 | |a α-glucosidase | ||
653 | |a kinase inhibitors | ||
653 | |a drug development | ||
653 | |a marine natural products | ||
653 | |a inhibitor | ||
653 | |a macroalgae | ||
653 | |a marine fish | ||
653 | |a protease | ||
653 | |a Ulva ohnoi | ||
653 | |a functional annotation | ||
653 | |a structure-function relation | ||
653 | |a natural products | ||
653 | |a bioactives | ||
653 | |a enzyme inhibition | ||
653 | |a inactivation | ||
653 | |a marine bacteria | ||
653 | |a marine fungi | ||
653 | |a marine sponges | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/3226 |7 0 |z Get Fullteks |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/69424 |7 0 |z DOAB: description of the publication |